PRTK - Paratek Pharmaceuticals GAAP EPS of -$1.22 misses by $0.31 revenue of $130.16M misses by $3.57M March, 14 2022 07:34 AM Paratek Pharmaceuticals Inc. Paratek Pharmaceuticals press release (NASDAQ:PRTK): FY GAAP EPS of -$1.22 misses by $0.31. Revenue of $130.16M (+177.4% Y/Y) misses by $3.57M. For further details see: Paratek Pharmaceuticals GAAP EPS of -$1.22 misses by $0.31, revenue of $130.16M misses by $3.57M